FDA launches initiative to reduce unnecessary radiation exposure from medical imaging
February 10, 2010
The U.S. Food and Drug Administration (FDA) announced on Tuesday a new initiative to reduce unnecessary radiation exposure from medical imaging. Specifically the FDA has targeted computed tomography (CT), nuclear medicine studies, and fluoroscopy as types of imaging that deliver much higher amounts of radiation to patients than standard x-rays, dental x-rays, and mammography.
Although medical imaging has significantly improved the chance for an early diagnosis and treatment, it has also increased the risks for patients to develop cancer due to the type radiation emitted: ionizing radiation. This type of radiation can accumulate over a patient's lifetime.
The FDA recommends that steps be taken to reduce unnecessary exposure to radiation by following these three steps:
- Promote safe use of medical imaging devices
- Support informed clinical decision making
- Increase patient awareness
To read more about this initiative, click here.
Document Library |
Membership entitles you to unlimited online access to our extensive library of quality and patient safety policies, procedures, and resources. This library is continuously updated with new and revised documents.
Question of the Month |
What kind of data do you get back from the PSO?
The PSO provides two major types of information that you get back as a member of the PSO. We break this into two categories:
-
... Read More...